Skip to main content
Glama

fda_drug_recalls

Read-onlyIdempotent

FDA drug enforcement actions (recalls). Filter by product name, recall classification (I=most severe, II, III), state, or date range. Useful for pharmacy compliance, supply chain monitoring, pharmacovigilance.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
limitNoMaximum rows to return (default 25, max 100).
queryNoOptional product description / generic name / brand name search term.
stateNoOptional 2-letter state filter.
end_dateNoInclusive ISO date upper bound (YYYY-MM-DD).
start_dateNoInclusive ISO date lower bound (YYYY-MM-DD).
classificationNoRecall severity: I (most severe), II, III.

TDQS

A3.6/5.0
Behavior3/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The annotations already declare readOnlyHint=true, idempotentHint=true, and destructiveHint=false, so the safety profile is fully covered. The description adds little beyond the recall domain and filter semantics; it does not mention pagination behavior, data source caveats, or what fields are returned. There is no contradiction with the annotations, so this is an acceptable but not exceptional disclosure.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is three short sentences with the core filtering capabilities front-loaded. The use-case sentence adds guidance without becoming bloated. There is no filler, repetition, or unnecessary detail.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no required parameters and every property described in the schema, an agent can assemble a valid call without additional documentation. The absence of an output schema is the main gap, but the domain statement gives a reasonable expectation that recall records are returned. Combined with read-only annotations, this is adequately complete for selection and invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

All six input-schema properties have descriptions, so schema coverage is 100% and the baseline is 3. The description recaps that query maps to product name and clarifies that classification I is most severe, but this largely duplicates schema information. It contributes no significant new meaning beyond what the schema already provides.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens by identifying the resource as 'FDA drug enforcement actions (recalls)' and immediately enumerates the filter dimensions: product name, classification, state, and date range. This makes the tool's intent clear and distinguishes it from siblings such as fda_food_recalls and fda_device_recalls by the explicit 'drug' scope. It lacks a strong imperative verb like 'search' or 'list,' but 'Filter by' conveys the retrieval behavior well enough.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The closing sentence names concrete use cases—pharmacy compliance, supply chain monitoring, pharmacovigilance—which tells an agent when this tool is relevant. It does not explicitly contrast with recall-related siblings like fda_food_recalls or fda_device_recalls, but the drug-specific framing and use-case cues imply the boundary. This is clear contextual guidance, though not exhaustive exclusion guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.2/5.0
Disambiguation2/5

Many tools overlap heavily across domains: caselaw_search vs court_case_search vs court_opinion_search, caselaw_citation_lookup vs court_citation_resolver, and a cluster of company due-diligence tools (company_trust_check, counterparty_risk_score, entity_dossier, issuer_diligence_dossier, kyb_aml_evidence_case_file) that all screen a company for sanctions/risk/standing. With 290 tools, an agent will frequently face multiple equally plausible choices for the same user intent.

Naming Consistency3/5

The vast majority of tools follow a clean domain-prefix + snake_case pattern (census_, eia_, fmcsa_, npi_, cfpb_, etc.), but there are notable exceptions: entity_resolve and resolve_entity are reversed duplicates, reg_search (Federal Register) sits next to reg_cfr_search (CFR) with confusingly similar names, and carrier_monitor_recheck deviates from the carrier_vetting_* family.

Tool Count1/5

290 tools is an extreme count under any rubric, far exceeding even the 50+ threshold for the lowest score. While the group-filtering mechanism and meta-tools like list_tool_groups and search_available_datasets mitigate the practical burden, the raw surface is still massively oversized for an agent to select from accurately and efficiently.

Completeness4/5

For a read-only data-aggregation server, coverage is remarkably comprehensive across 59 domains, and generic fallbacks like cdc_dataset_query, eia_series_lookup, fred_observations, and bls_series prevent most dead ends. Minor gaps exist (a single GitHub tool, demo-only property_lookup coverage, no write/update operations anywhere), but the stated data-access purpose is well served.

Resources